| Industry | 信息传输、软件和信息技术服务业 | ||||||||||||||||||||||||
| Company Introduction | 嘉和美康是国内最早从事医疗信息化软件研发与产业化的企业之一，长期深耕临床信息化领域。公司主营业务为医疗信息化软件产品研发、销售及技术服务。经过十余年的发展，公司建立了以电子病历为核心的临床业务数据采集、以医院数据中心为主的医疗数据处理、以医疗大数据创新为主的数据应用服务生态闭环。目前，已经形成了覆盖临床医疗、医院管理、医学科研、医患互动、医养结合、医疗支付优化等产业链环节的产品体系，致力于向医疗相关机构提供综合信息化解决方案。 公司现有主要产品包括电子病历平台、医院数据中心、智慧医疗产品、互联网医疗产品。截至2021年末，全国范围内已有1500余家大中型医疗机构在嘉和信息系统的支持下开展诊疗服务；数十家养老服务企业、健康管理企业在嘉和健康养老云的支持下开展机构及居家社区养老和人群健康管理服务。 | ||||||||||||||||||||||||
| Main Business | 医疗信息化软件产品研发、销售及技术服务 | ||||||||||||||||||||||||
| Legal Representative | 夏军 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 李静 | ||||||||||||||||||||||||
| Solicitors | 北京市中伦律师事务所 | ||||||||||||||||||||||||
| Auditors | 大华会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 010-82781910 | ||||||||||||||||||||||||
| Fax No | 010-82781910 | ||||||||||||||||||||||||
| Website | www.bjgoodwill.com | ||||||||||||||||||||||||
| zqb@bjgoodwill.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 14/12/2021 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.310 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 13.251 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 2.774B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |